Emerging Research Directions Several ongoing studies are examining combination metabolic therapies: Phase II trials investigating L-carnitine plus tirzepatide specifically in patients with metabolic syndrome Research examining acetyl-L-carnitine's cognitive benefits in patients experiencing "brain fog" during GLP-1 therapy Studies assessing whether L-carnitine supplementation reduces the muscle loss sometimes observed with rapid weight reduction Results from these investigations will help establish evidence-based protocols for combination therapy and may influence future prescribing guidelines
Cribb AE, Lee BL, Trepanier LA, Spielberg SP
Serious adverse effects are rare when taken as prescribed under medical supervision
Liu B, Yi W, Mao X, Yang L, Rao C
If the FDA ultimately gets its way, any mass-compounding of GLP-1s at the 503B level will grind to a halt
Here, we examine persistent effects of short-term (24 hour, hr) developmental BPA exposure on the visual system in zebrafish ( Danio rerio )